[go: up one dir, main page]

HK1120218A - The use of beta-aminoalcohols in the treatment of inflammatory disorders and pain - Google Patents

The use of beta-aminoalcohols in the treatment of inflammatory disorders and pain Download PDF

Info

Publication number
HK1120218A
HK1120218A HK08113096.8A HK08113096A HK1120218A HK 1120218 A HK1120218 A HK 1120218A HK 08113096 A HK08113096 A HK 08113096A HK 1120218 A HK1120218 A HK 1120218A
Authority
HK
Hong Kong
Prior art keywords
aminoalcohols
pain
beta
treatment
inflammatory disorders
Prior art date
Application number
HK08113096.8A
Other languages
Chinese (zh)
Inventor
John Brew
Andrew Douglas Baxter
Robin Mark Bannister
Original Assignee
Sosei R&D Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sosei R&D Ltd. filed Critical Sosei R&D Ltd.
Publication of HK1120218A publication Critical patent/HK1120218A/en

Links

HK08113096.8A 2006-03-09 2007-03-09 The use of beta-aminoalcohols in the treatment of inflammatory disorders and pain HK1120218A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0604822.7 2006-03-09

Publications (1)

Publication Number Publication Date
HK1120218A true HK1120218A (en) 2009-03-27

Family

ID=

Similar Documents

Publication Publication Date Title
IL181706A0 (en) The treatment of inflammatory disorders and pain
EP2114419B8 (en) Sodium meta arsenite for use in the treatment of pain and inflammation
ZA200806114B (en) Use of sulfonamide derivatives in the treatment of disorders of the metabolism and the nervous system
PL2390255T3 (en) Novel aminoglycosides and uses thereof in the treatment of genetic disorders
IL218851A0 (en) Use of dimiracetam in the treatment of chronic pain
IL199214A0 (en) New combination for use in the treatment of inflammatory disorders
IL193943A0 (en) The use of beta- aminoalcohols for the treatment of inflammatory disorders and pain
IL193944A0 (en) The use beta-aminoalcohols for the treatment of inflammatory disorders and pain
HK1120218A (en) The use of beta-aminoalcohols in the treatment of inflammatory disorders and pain
GB0419828D0 (en) The treatment of inflammatroy disorders and pain
HK1120217A (en) The use of beta-aminoalcohols for the treatment of inflammatory disorders and pain
GB0513413D0 (en) The treatment of inflammatory disorders and pain
GB0609794D0 (en) The treatment of inflammatory disorders and pain
GB0622476D0 (en) The treatment of inflammatory disorders and pain
GB0502596D0 (en) The treatment of inflammatory disorders and pain
HK1099702A (en) The treatment of inflammatory disorders and pain
GB0703494D0 (en) The treatment of inflammatory disorders and pain
GB0718279D0 (en) The treatment of inflammatory disorders and pain
GB0711769D0 (en) The treatment of inflammatory disorders and pain
GB0722524D0 (en) The treatment of inflammatory disorders and pain
PL2224934T3 (en) Use of osteoblasts in the treatment of inflammatory rheumatic diseases
GB0423926D0 (en) The treatment of Inflammatory disorders and pain
GB0817330D0 (en) The treatment of inflammatory disorders and pain
GB0803397D0 (en) The treatment of inflammatory disorders and pain
HK1111892A (en) Use of pyrazolyl-pyrimidine derivatives in the treatment of pain